Skip to main navigation
White Oncorus Logo

Our next-generation viral immunotherapies pack a powerful trio of attributes – selective attack, potent destruction, and broad immune stimulation – to enable the potential to transform outcomes for patients.

  • About Us
  • Our Technology
  • Pipeline
  • Culture & Careers
  • Investors & Media
  • Contact Us
  • Privacy Policy
  • Terms of Use
Oncorus Logo
  • About Us
  • Our Technology
  • Pipeline
  • Culture & Careers
  • Investors & Media

Investor Relations

Overview
News & Events
News Releases
Events and Presentations
Stock Information
Stock Quote & Chart
Historic Price Lookup
Investment Calculator
Analyst Coverage
Corporate Governance
Governance Documents
Management Team
Board of Directors
Committee Composition
Scientific Advisory Board
Financials & Filings
SEC Filings
Investor Resources
Investor FAQs
Email Alerts
Contact IR
Page Navigation

Search

Filter by content type

Filter by content year

Filter by form group

Filter by tags

Filter by category

Filter by type

Filter by category

Filter by category

Filter by category

Contact Information

ir@oncorus.com
media@oncorus.com

Toolkit

Shareholder Tools

Email Alerts

RSS

Print

Email Page

Search

Oncorus Footer Logo

Our next-generation viral immunotherapies pack a powerful trio of attributes – selective attack, potent destruction, and broad immune stimulation – to enable the potential to transform outcomes for patients.

Social Links

© 2023 Oncorus, Inc. All Rights Reserved.

  • About Us
  • Our Technology
  • Pipeline
  • Culture & Careers
  • Investors & Media
  • Contact Us
  • Privacy Policy
  • Terms of Use
Top